.Amgen has shared (PDF) the initial phase 3 data on its $400 thousand eczema medication, connecting ...
.Biogen and UCB's bet one's bottom dollar advancing into period 3 on the back of an unsuccessful stu...
.Italian biotech Aptadir Therapies has actually launched with the commitment that its own pipeline o...
.Surge Life Sciences has actually met its own objective in a Duchenne muscular dystrophy (DMD) study...
.After a handful of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, usin...
.Achilles Therapeutics has shreded its strategy. The British biotech is actually quiting working on ...
.Aligos Therapies is actually heralding a midstage win in metabolic-dysfunction linked steatohepatit...
.Basilea Pharmaceutica's job building brand-new antifungals has obtained a substantial increase from...
.Having currently scooped up the united state civil rights to Capricor Therapeutics' late-stage Duch...
.After dismissing the selection meeting for Applied Rehabs' metabolic condition medicine govorestat,...